Cellusion welcomes Dr. Naonori Kurokawa and Dr. Hiroaki Kobayashi to the Management Team

Cellusion welcomes Stella and Toru as new board members

CLS001 Clinical Study Plan Officially Approved by MHLW‘s Health Science Council

The Clinical Study Plan on Corneal Endothelial Cell Substitute from iPS Cells Transplant Plan for Bullous Keratopathy Patient approved by MHLW‘s Health Science Council

Keio Univ.’s Corneal Endothelial Cell Substitute from iPS Cells Transplant Plan on Bullous Keratopathy Treatment OK’d

Cellusion raises additional funding and welcomes a new board member

Cellusion raises 360M JPY in series A funding

Cellusion has been selected Tokyo metropolitan government R&D facility support grant 2019.

Cellusion has been selected to NEDO STS program 2019